niacin and ketamine
niacin has been researched along with ketamine in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kohjitani, A; Obara, H; Okada, S; Shirakawa, J | 1 |
| Ibrahim, WW; Kandil, EA; Sayed, RH; Wadie, W | 1 |
Reviews
1 review(s) available for niacin and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
4 other study(ies) available for niacin and ketamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The relaxing effect of ketamine on isolated rabbit lower esophageal sphincter.
Topics: Adenylyl Cyclases; Anesthetics, Dissociative; Animals; Atropine; Bucladesine; Calcium; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esophagogastric Junction; In Vitro Techniques; Isoquinolines; Ketamine; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Niacin; Protein Kinase Inhibitors; Rabbits; Sulfonamides | 1997 |
Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Encephalitis; Hypolipidemic Agents; Ketamine; Male; Niacin; Psychotic Disorders; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Tight Junction Proteins | 2022 |